Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Integration of Complementary & Conventional Care for Patients with Musculoskeletal Disorders

Vanessa Caceres  |  May 8, 2023

Studies related to acupuncture and tai chi show some benefits for patients with musculoskeletal disorders, such as fibromyalgia and osteoarthritis. When patients ask about these integrative health approaches, rheumatologists should recommend they use qualified, experienced practitioners.

A Conversation with Rheumatology Research Foundation VP Liana Fraenkel, MD, MPH

Leslie Mertz, PhD  |  May 5, 2023

Liana Fraenkel, MD, MPH, likes to fix things, and the dynamic and challenging field of rheumatology always has room for improvement. That mindset has led her down some interesting paths as a researcher and healthcare provider, and as vice president of the Rheumatology Research Foundation. Dr. Fraenkel was a rheumatologist and researcher at the Yale…

The Effect of Upadacitinib on Bone Erosion in Patients with RA

Michele B. Kaufman, PharmD, BCGP  |  May 2, 2023

Ho et al. found that upadacitinib may impede the progression of bone erosion in patients with RA. Additionally, bone scans of patients with limited exposure to conventional synthetic disease-modifying antirheumatic drugs showed bone erosion regression, which may result from upadacitinib’s inhibition of Janus kinase 1.

Peresolimab Promising for RA

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2023

Stimulating human programmed cell death protein 1 (PD-1), a checkpoint inhibitory receptor, with peresolimab may be a viable way to treat autoimmune diseases, according to a study by Tuttle et al. In the study, patients with active rheumatoid arthritis (RA) who were treated with peresolimab experienced greater improvements in disease activity than those who received placebo.

Lessons from Master Clinicians: An Interview with Dr. Richard Brasington

Jason Liebowitz, MD, FACR  |  May 1, 2023

Editor’s note: We at The Rheumatologist are saddened to hear of the passing of Richard Brasington Jr., MD, FACP, MACR. Dr. Brasington leaves a legacy of excellence as an outstanding clinician, educator, scholar and more.  One of the many ways that he contributed to our community was as the associate editor of The Rheumatologist between…

Lessons from Master Clinicians: An Interview with Dr. Richard Brasington

Jason Liebowitz, MD, FACR  |  May 1, 2023

Editor’s note: We at The Rheumatologist are saddened to hear of the passing of Richard Brasington Jr., MD, FACP, MACR. Dr. Brasington leaves a legacy of excellence as an outstanding clinician, educator, scholar and more.  One of the many ways that he contributed to our community was as the associate editor of The Rheumatologist between…

Sunny San Diego to Welcome ACR Convergence 2023

Vanessa Caceres  |  May 1, 2023

An in-person poster hall and networking lounges are among the highlights attendees can expect at ACR Convergence 2023 in San Diego, Nov. 10–15.

JAK Inhibitors vs. TNF Inhibitors: Understanding Infection Risks

Michele B. Kaufman, PharmD, BCGP  |  April 27, 2023

Research from Choi et al. provides insights into the risk of infection in patients with rheumatoid arthritis (RA), comparing patients treated with Janus kinase inhibitors vs. tumor necrosis inhibitors. The most frequent infection was herpes zoster, with patients treated with JAK inhibitors having a significantly greater risk of herpes zoster infection than those treated with TNF inhibitors.

Help Your Legislators Understand the Ins & Outs of Patient Care

Christina Downey, MD  |  April 25, 2023

With an influx of new faces in the 118th Congress, Government Affairs Committee Chair Christina Downey, MD, notes that now is a great time to establish a relationship with your member of Congress and help them understand the day-to-day of what it takes to take care of patients.

Platelets in the Pathogenesis of SLE

Arthritis & Rheumatology  |  April 24, 2023

In a study, El Bannoudi et al. found that platelets contribute to the pathogenesis of SLE by secreting the proinflammatory platelet-associated lectin, galactoside-binding, soluble 3 binding protein (LGALS3BP), which also represents a novel biomarker of SLE clinical activity.

  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences